ATE309358T1 - Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein - Google Patents
Superaktive, wachstumshormone freisetzende hormonanaloge vom schweinInfo
- Publication number
- ATE309358T1 ATE309358T1 AT00953666T AT00953666T ATE309358T1 AT E309358 T1 ATE309358 T1 AT E309358T1 AT 00953666 T AT00953666 T AT 00953666T AT 00953666 T AT00953666 T AT 00953666T AT E309358 T1 ATE309358 T1 AT E309358T1
- Authority
- AT
- Austria
- Prior art keywords
- growth
- growth hormone
- animal
- hormone
- superactive
- Prior art date
Links
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 title abstract 4
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 title abstract 4
- 101710142969 Somatoliberin Proteins 0.000 title abstract 4
- 235000015277 pork Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 abstract 6
- 102000018997 Growth Hormone Human genes 0.000 abstract 5
- 108010051696 Growth Hormone Proteins 0.000 abstract 5
- 239000000122 growth hormone Substances 0.000 abstract 5
- 230000007812 deficiency Effects 0.000 abstract 3
- 208000026350 Inborn Genetic disease Diseases 0.000 abstract 2
- 208000016361 genetic disease Diseases 0.000 abstract 2
- 208000027219 Deficiency disease Diseases 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 230000009001 hormonal pathway Effects 0.000 abstract 1
- 238000009163 protein therapy Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14562499P | 1999-07-26 | 1999-07-26 | |
PCT/US2000/020127 WO2001006988A2 (en) | 1999-07-26 | 2000-07-24 | Super-active porcine growth hormone releasing hormone analog |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE309358T1 true ATE309358T1 (de) | 2005-11-15 |
Family
ID=22513900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00953666T ATE309358T1 (de) | 1999-07-26 | 2000-07-24 | Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein |
Country Status (13)
Country | Link |
---|---|
US (3) | US6551996B1 (de) |
EP (1) | EP1204321B1 (de) |
JP (1) | JP4644402B2 (de) |
KR (1) | KR20020047096A (de) |
CN (1) | CN1635898A (de) |
AT (1) | ATE309358T1 (de) |
AU (1) | AU772752B2 (de) |
BR (1) | BR0012748A (de) |
CA (1) | CA2378943C (de) |
DE (1) | DE60023906T2 (de) |
MX (1) | MXPA02000938A (de) |
PL (1) | PL366132A1 (de) |
WO (1) | WO2001006988A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040192593A1 (en) * | 1999-07-26 | 2004-09-30 | Baylor College Of Medicine | Protease resistant ti-growth hormone releasing hormone |
US20030074679A1 (en) * | 2000-12-12 | 2003-04-17 | Schwartz Robert J. | Administration of nucleic acid sequence to female animal to enhance growth in offspring |
AR035671A1 (es) * | 2000-12-12 | 2004-06-23 | Advisys Inc | Administracion de secuencia de acido nucleico a un animal hembra, para aumentar el crecimiento de la descendencia |
US20030157717A1 (en) * | 2001-09-07 | 2003-08-21 | Baylor College Of Medicine Texas Medical Center | Linear DNA fragments for gene expression |
MXPA04003944A (es) * | 2001-10-26 | 2004-07-08 | Baylor College Medicine | Una composicion y metodo para alterar la masa corporal fina y propiedades oseas en un sujeto. |
AU2002357143B2 (en) | 2001-12-11 | 2009-07-30 | Advisys, Inc. | Growth hormone releasing hormone supplementation for treating chronically ill subjects |
MXPA04007638A (es) * | 2002-02-07 | 2004-12-06 | Baylor College Medicine | Desarrollo modificado de la glandula pituitaria en productos de madres animales prenadas, tratadas con terapia de hormona liberadora de hormona del crecimiento. |
MXPA04011766A (es) * | 2002-05-28 | 2005-03-31 | Advisys Inc | SUMINISTRO AUMENTADO DE UNA CONSTRUCCION DE áCIDO NUCLEICO IN VIVO POR EL SISTEMA DE POLO-L-GLUTAMATO (PLG). |
WO2004007678A2 (en) * | 2002-07-16 | 2004-01-22 | Advisys, Inc. | Codon optimized synthetic plasmids |
US20060128615A1 (en) * | 2002-09-18 | 2006-06-15 | Pierrette Gaudreau | Ghrh analogues |
WO2004067719A2 (en) * | 2003-01-28 | 2004-08-12 | Advisys, Inc. | Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals |
US7361642B2 (en) * | 2003-08-04 | 2008-04-22 | Vgx Pharmaceuticals, Inc. | Canine specific growth hormone releasing hormone |
US7442673B2 (en) * | 2003-08-15 | 2008-10-28 | Crompton Corporation | Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
WO2005065722A2 (en) * | 2003-12-31 | 2005-07-21 | Advisys, Inc. | Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
US20090005333A1 (en) * | 2004-01-26 | 2009-01-01 | Vgx Pharmaceuticlas, Inc. | Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
US7846720B2 (en) * | 2005-01-26 | 2010-12-07 | Vgx Pharmaceuticals, Inc. | Optimized high yield synthetic plasmids |
JP5649825B2 (ja) | 2007-01-31 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | 安定化させたp53ペプチドおよびその使用法 |
KR20160061439A (ko) | 2007-03-28 | 2016-05-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
US8226468B2 (en) * | 2008-11-13 | 2012-07-24 | Igt | Gaming system and method including points of symbol expansion |
US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
US20100267635A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechonolgies Inc. | Use of protease inhibitors and grf molecules in combination therapy |
KR102104762B1 (ko) | 2010-08-13 | 2020-04-24 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
US8993316B2 (en) | 2011-11-16 | 2015-03-31 | Brian P. Hanley | Methods and compositions for gene therapy and GHRH therapy |
CN102516364B (zh) * | 2011-12-26 | 2013-11-06 | 吉林农业大学 | 一种模拟猪生长激素样的活性肽及制备方法与应用 |
CN104144695A (zh) | 2012-02-15 | 2014-11-12 | 爱勒让治疗公司 | ***交联的和硫醚交联的拟肽大环化合物 |
CN107216380A (zh) | 2012-02-15 | 2017-09-29 | 爱勒让治疗公司 | 拟肽大环化合物 |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
KR20150082307A (ko) | 2012-11-01 | 2015-07-15 | 에일러론 테라퓨틱스 인코포레이티드 | 이치환 아미노산 및 이의 제조 및 사용 방법 |
BR112017005598A2 (pt) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | macrociclos peptidomiméticos e usos dos mesmos |
EP3294318A4 (de) | 2015-03-20 | 2019-04-03 | Aileron Therapeutics, Inc. | Peptidomimetische makrozyklen und verwendungen davon |
JP7134093B2 (ja) | 2016-04-19 | 2022-09-09 | グリフォン・ファーマシューティカルズ・アンテルナシオナル・エスアー | ペグ化バイオアクティブペプチド及びその使用 |
CN112724260B (zh) * | 2021-01-15 | 2021-11-30 | 安徽中起生物科技有限公司 | 一种脂质体包封的重组兽用促生长蛋白及其制备方法和应用 |
CN113582881B (zh) * | 2021-07-29 | 2022-10-11 | 浙江新码生物医药有限公司 | 一种非天然氨基酸及其应用、包含其的重组蛋白以及重组蛋白偶联物 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4410512A (en) | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
US5036045A (en) | 1985-09-12 | 1991-07-30 | The University Of Virginia Alumni Patents Foundation | Method for increasing growth hormone secretion |
US4839344A (en) | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
USRE33699E (en) | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
US5023322A (en) | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
US5084442A (en) | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
US5137872A (en) | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
AU7174791A (en) | 1990-01-26 | 1991-08-21 | Baylor College Of Medicine | Mutated promoter region from chicken skeletal alpha-actin gene |
EP0544706A4 (en) | 1990-06-29 | 1993-10-13 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
US5486505A (en) | 1990-07-24 | 1996-01-23 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
CA2084061A1 (en) | 1991-04-09 | 1992-10-10 | Arthur M. Felix | Growth hormone releasing factor analogs |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5298422A (en) | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
RU2167881C2 (ru) * | 1993-12-23 | 2001-05-27 | Ново Нордиск А/С | Соединения, способствующие высвобождению гормона роста |
US5792747A (en) | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
EP0820296A4 (de) | 1995-04-14 | 1999-06-30 | Univ Tulane | Analoge von wachstumshormon-freisetzungsfaktor |
AU7522896A (en) * | 1995-10-27 | 1997-05-15 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
US6123964A (en) | 1995-10-27 | 2000-09-26 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
US6221617B1 (en) * | 1996-12-06 | 2001-04-24 | Julie Heinrich | Bioassay for growth hormone releasing hormone |
AU7906998A (en) * | 1997-06-20 | 1999-01-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6127341A (en) | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
JP2001511353A (ja) * | 1997-07-24 | 2001-08-14 | バレンティス・インコーポレーテッド | Ghrhの発現システムおよび使用法 |
WO2001066149A2 (en) * | 2000-03-03 | 2001-09-13 | Valentis, Inc. | Nucleic acid formulations for gene delivery and methods of use |
-
2000
- 2000-07-24 PL PL00366132A patent/PL366132A1/xx not_active Application Discontinuation
- 2000-07-24 CN CNA008133727A patent/CN1635898A/zh active Pending
- 2000-07-24 JP JP2001511880A patent/JP4644402B2/ja not_active Expired - Lifetime
- 2000-07-24 EP EP00953666A patent/EP1204321B1/de not_active Expired - Lifetime
- 2000-07-24 US US09/624,268 patent/US6551996B1/en not_active Expired - Lifetime
- 2000-07-24 BR BR0012748-5A patent/BR0012748A/pt not_active IP Right Cessation
- 2000-07-24 WO PCT/US2000/020127 patent/WO2001006988A2/en active IP Right Grant
- 2000-07-24 AT AT00953666T patent/ATE309358T1/de not_active IP Right Cessation
- 2000-07-24 KR KR1020027001095A patent/KR20020047096A/ko not_active Application Discontinuation
- 2000-07-24 DE DE60023906T patent/DE60023906T2/de not_active Expired - Lifetime
- 2000-07-24 AU AU66078/00A patent/AU772752B2/en not_active Expired
- 2000-07-24 CA CA2378943A patent/CA2378943C/en not_active Expired - Lifetime
- 2000-07-24 MX MXPA02000938A patent/MXPA02000938A/es active IP Right Grant
-
2002
- 2002-10-01 US US10/262,377 patent/US20030148948A1/en not_active Abandoned
- 2002-10-01 US US10/262,141 patent/US7166461B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1635898A (zh) | 2005-07-06 |
CA2378943A1 (en) | 2001-02-01 |
MXPA02000938A (es) | 2004-03-19 |
WO2001006988A2 (en) | 2001-02-01 |
DE60023906T2 (de) | 2006-07-20 |
BR0012748A (pt) | 2003-06-10 |
DE60023906D1 (de) | 2005-12-15 |
PL366132A1 (en) | 2005-01-24 |
CA2378943C (en) | 2012-09-18 |
US20030129172A1 (en) | 2003-07-10 |
WO2001006988A3 (en) | 2001-08-09 |
US7166461B2 (en) | 2007-01-23 |
JP4644402B2 (ja) | 2011-03-02 |
US6551996B1 (en) | 2003-04-22 |
AU772752B2 (en) | 2004-05-06 |
KR20020047096A (ko) | 2002-06-21 |
EP1204321B1 (de) | 2005-11-09 |
US20030148948A1 (en) | 2003-08-07 |
EP1204321A2 (de) | 2002-05-15 |
EP1204321A4 (de) | 2002-11-06 |
JP2003517294A (ja) | 2003-05-27 |
AU6607800A (en) | 2001-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE309358T1 (de) | Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein | |
EP0429586A4 (en) | Growth hormone fusion proteins | |
DE69233188D1 (de) | Hormonanaloge mit mehreren ctp-erweiterungen | |
ATE319827T1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
CA2383136A1 (en) | Obg3 globular head and uses thereof for decreasing body mass | |
ATE257859T1 (de) | Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit | |
ATE84707T1 (de) | Implantate mit verzoegerter abgabe fuer die anwendung von rekombinanten wachstumshormonen. | |
WO2002060921A3 (en) | Enhancement of immune response to vaccine by interferon alpha | |
ATE464378T1 (de) | Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung | |
IL102346A0 (en) | Cysteine depleted il-6 muteins | |
DE69831979D1 (de) | Gefrorenes lebensmittel | |
ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
EP0561877A4 (de) | ||
EP1321473A4 (de) | Verfahren zur prävention einer abnahme der proteinaktivität, basierend auf gefrieren und verwendung eines polypeptids in der produktion von agenzien, welche die proteinaktivität herabsetzen | |
JPH01131198A (ja) | Pth修飾物およびpth修飾物含有またはpth修飾物からなる治療組成物 | |
EP0191869A4 (de) | Fisch-kalzitoninabkömmling und dessen herstellung und gensystem dafür. | |
ATE405584T1 (de) | Arginin/lysin-angereicherte peptide | |
DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
AU2003222959A1 (en) | Use of alpha-s2 casein precursor-derived peptided | |
DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
ATE282704T1 (de) | Isolierte und gereinigte humane lösliche guanylylcyclase alpha1/beta1 (hsgc alpha1/beta1) | |
Leonard | Sri Lankans battle nature | |
Rodriguez-Romo et al. | The feeding-dung scarabs of Caceres province(Spain): Scarabaeini, Coprini, Onitini and Oniticellini(Col. Scarabaeidae). | |
WO2003035856A3 (en) | Protein with kinase activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |